A therapeutic approach to erythrodermic psoriasis: Report of a case and a discussion of therapeutic options

Acta Dermato-Venereologica

Volumn 76, Issue 1, 1996, Pages 65-67

  Van Der Vleuten, C J M ^a   Gerritsen, M J P ^a   Steijlen, P M ^a   De Jong, E M G J ^a   Van De Kerkhof, P C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Calcipotriol; Combination therapy; Cyclosporine; UVB

Indexed keywords

CALCIPOTRIOL; CLOBETASOL PROPIONATE; CYCLOSPORIN; ETRETIN; HYDROCORTISONE; METHOTREXATE; TAR;

AGED; ARTICLE; CASE REPORT; CLINICAL TRIAL; ERYTHRODERMA; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSORIASIS; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET B RADIATION;

AGED; CALCITRIOL; COMBINED MODALITY THERAPY; CYCLOSPORINE; DERMATITIS, EXFOLIATIVE; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PSORIASIS; ULTRAVIOLET THERAPY;

EID: 0029985693     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Zip C, Murray S, Walsh NM. The specificity of histopathology in erythroderma. J Cutan Pathol 1993; 20: 393-398.
2. Boyd AS, Menter A. Erythrodermic psoriasis. Precipitating factors, course, and prognosis in 50 patients. J Am Acad Dermatol 1989; 21: 985-991.
3. Nicolis GD, Helwig EB. Exfoliative dermatitis. A clinicopathologic study of 135 cases. Arch Dermatol 1973; 108: 788-797.
4. Beck HI, Foged EK. Toxic hepatitis due to combination therapy with methotrexate and etretinate in psoriasis. Dermatologica 1983; 167: 94-96.
5. Tuyp E, MacKie RM. Combination therapy for psoriasis with methotrexate and etretinate. J Am Acad Dermatol 1986; 14: 70-73.
6. Brechtel B, Wellenreuther U, Toppe E, Czarnetzki BM. Combination of etretinate with cyclosporine in the treatment of severe recalcitrant psoriasis. J Am Acad Dermatol 1994; 30: 1023-1024.
7. Korstanje MJ, Bessems PJ, van de Staak WJ. Combination therapy ciclosporin-etretinate effective in erythrodermic psoriasis [letter]. Dermatologica 1989; 179: 94.
8. Lowe NJ, Prystowsky JH, Bourget T, Edelstein J, Nychay S, Armstrong R. Acitretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acitretin alone. J Am Acad Dermatol 1991; 24: 591-594.
9. Saurat JH, Geiger JM, Amblard P, Beani JC, Boulanger A, Claudy A, et al. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis. Dermatologica 1988; 177: 218-224.
10. Korstanje MJ, van Breda Vriesman CJ, van de Staak WJ. Cyclosporine and methotrexate: a dangerous combination. J Am Acad Dermatol 1990; 23: 320-321.
11. Farber EM, Nall L. Erythrodermic (exfoliative) psoriasis. Cutis 1993; 51: 79-82.
12. Berth Jones J, Hutchinson PE. Progress in self treatment for psoriasis vulgaris. J Clin Pharmacol Ther 1992; 17: 217-222.
13. Kragballe K, Gjertsen BT, De Hoop D, Karlsmark T, van de Kerkhof PC, Larkö O, et al. Double-blind, right left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris [published erratum appears in Lancet 1991 Apr 20;337(87471:988]. Lancet 1991; 337: 193-196.
14. Berth Jones J, Bourke J, Bailey K, Graham Brown RA, Hutchinson PE. Generalised pustular psoriasis: response to topical calcipotriol. BMJ 1992; 305: 868-869.
15. Gray JD, Bottomley W, Layton AM, Cotterill JA, Monteiro E. The use of calcipotriol in HIV-related psoriasis. Clin Exp Dermatol 1992; 17: 342-343.
16. Texereau M, Viac J. Vitamin D, immune system and skin. Eur J Dermatol 1992; 2: 258-264.
17. Milde P, Hauser U, Simon T, Mall G, Ernst V, Haussler MR, et al. Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin. J Invest Dermatol 1991; 97: 230-239.
18. Bittiner B, Bleehen SS, MacNeil S. 1 alpha,25(OH)2 vitamin D3 increases intracellular calcium in human keratinocytes. Br J Dermatol 1991; 124: 230-235.
19. Binderup L, Bramm E. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 1988; 37: 889-895.
20. de Jong EM, van de Kerkhof PC. Simultaneous assessment of inflammation and epidermal proliferation in psoriatic plaques during long-term treatment with the vitamin D3 analogue MC903: modulations and interrelations. Br J Dermatol 1991; 124: 221-229.
21. Muller K, Svenson M, Bendtzen K. 1 alpha,25-dihydroxyvitamin D3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin 1 in vitro. Immunol Lett 1988; 17: 361-365.
22. Oxholm A, Oxholm P, Staberg B, Bendtzen K. Expression of interleukin-6-like molecules and tumour necrosis factor after topical treatment of psoriasis with a new vitamin D analogue (MC 903). Acta Derm Venereol (Stockh) 1989; 69: 385-390.
23. Grossman RM, Thivolet J, Claudy A, Souteyrand P, Guilhou JJ, Thomas P, et al. A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: results of a multicenter placebo-controlled study. J Am Acad Dermatol 1994; 31: 68-74.
24. Kragballe K. Combination of topical calcipotriol (MC 903) and UVB radiation for psoriasis vulgaris. Dermatologica 1990; 181: 211-214.
25. Kerscher M, Volkenandt M, Plewig G, Lehmann P. Combination phototherapy of psoriasis with calcipotriol and narrow-band UVB [letter]. Lancet 1993; 342: 923.
26. Gupta S, Fass D, Shimizu M, Vayuvegula B. Potentiation of immunosuppressive effects of cyclosporin A by 1 alpha,25-dihydroxyvitamin D3. Cell Immunol 1989; 121: 290-297.
27. Gepner P, Amor B, Fournier C. 1,25-dihydroxyvitamin D3 potentiates the in vitro inhibitory effects of cyclosporin A on T cells from rheumatoid arthritis patients. Arthritis Rheum 1989; 32: 31-36.
28. Fournier C, Gepner P, Sadouk M, Charreire J. In vivo beneficial effects of cyclosporin A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis. Clin Immunol Immunopathol 1990; 54: 53-63.
29. Bagot M, Charue D, Pamphile RP, Revuz J. Calcipotriol potentiates the immunosuppressive effects of cyclosporine A in allogeneic reactions [Abstract]. J Invest Dermatol 1991; 96: 1023.
30. Furue M, Gaspari AA, Katz SI. The effect of cyclosporin A on epidermal cells. II. Cyclosporin A inhibits proliferation of normal and transformed keratinocytes. J Invest Dermatol 1988; 90: 796-800.
31. Bagot M, Charue D, Lescs MC, Pamphile RP, Revuz J. Immunosuppressive effects of 1,25-dihydroxyvitamin D3 and its analogue calcipotriol on epidermal cells. Br J Dermatol 1994; 130: 424-431.